CLINICAL TRIAL: A PHASE III DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF LONG TERM

$687M01FY2009RRNIH

University Of New Mexico, Albuquerque NM

Investigators

Linked publications, trials & patents

Paper 34166655 Paper 33478957 Paper 32446491 Paper 32111975 Paper 31691959 Paper 31427096 Paper 30737489 Paper 30631138 Paper 30487263 Paper 29872859 Paper 29256014 Paper 28526635 Paper 28283553 Paper 28279433 Paper 28199816 Paper 28120833 Paper 27766453 Paper 27455401 Paper 27423510 Paper 27321735 Paper 27142425 Paper 27074126 Paper 26938991 Paper 26865065 Paper 26305897 Paper 26080344 Paper 25145603 Paper 25117418 Paper 25102180 Paper 25018787 Paper 24973415 Paper 24931849 Paper 24931401 Paper 24698320 Paper 24627273 Paper 24531051 Paper 24529412 Paper 24447284 Paper 24378638 Paper 24370654 Paper 24139497 Paper 24135709 Paper 24083102 Paper 24067395 Paper 24060318 Paper 24029427 Paper 23905525 Paper 23867958 Paper 23802814 Paper 23797178 Paper 23770473 Paper 23576689 Paper 23567488 Paper 23498594 Paper 23441775 Paper 23437687 Paper 23389640 Paper 23361338 Paper 23054848 Paper 23015512 Paper 22994713 Paper 22982287 Paper 22926660 Paper 22873489 Paper 22847383 Paper 22814942 Paper 22773292 Paper 22748517 Paper 22744621 Paper 22720802 Paper 22644414 Paper 22562288 Paper 22551995 Paper 22492987 Paper 22453668 Paper 22421261 Paper 22412148 Trial NCT01235923 Trial NCT01223287 Trial NCT01203514 Trial NCT01203501 Trial NCT01203488 Trial NCT01203475 Trial NCT01203449 Trial NCT01203423 Trial NCT01035697 Trial NCT00874367 Trial NCT00320086 Trial NCT00109525 Trial NCT00067613 Trial NCT00063063 Trial NCT00011362 Trial NCT00009646 Trial NCT00009633 Trial NCT00009620 Trial NCT00005777 Trial NCT00005776 Trial NCT00005775 Trial NCT00005774 Trial NCT00005773

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Purpose of this study is to test whether prolonged oral antiviral therapy improves long term outcome of herpes simplex encephalitis [HSE] following standard IV antiviral treatment. Specific questions being looked at are: 1- Does long term oral valacyclovir improve outcomes in HSE? 2- How does the body absorb, metabolize, and eliminate high dose oral valacyclovir when used long term for HSE? 3- Is there a relationship between neurologic outcomes following HSE and the amount of Herpes Simplex virus in the Central Nervous System?

View original record on NIH RePORTER →